Attached files

file filename
10-Q - US-China Biomedical Technology, Inc.accendmayq.txt
EX-32.1 - SECTION 906 CERTIFICATION - US-China Biomedical Technology, Inc.ex321sec906.txt

Exhibit 31.1 -- Principal Executive Officer and Principal Financial Officer
                Certification  (Section 302)

                  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                        AND PRINCIPAL FINANCIAL OFFICER


            Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002


                                  CERTIFICATION

I, Scott Gerardi, certify that:

     1.   I have reviewed this report on Form 10-Q of Accend Media;

     2.   Based on my knowledge, this report does not contain any untrue
          statement of a material fact or omit to state a material fact
          necessary to make the statements  made, in light of the circumstances
          under which such statements were made, not misleading with respect to
          the period covered by this report;

     3.   Based on my knowledge, the financial statements, and other financial
          information included in this report, fairly present in all
          material respects the financial condition, results of operations and
          cash flows of the registrant as of, and for, the periods presented
          in this report;

     4.   I am responsible for establishing and maintaining disclosure controls
          and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-
          15(e)) and internal control over financial reporting (as defined in
          Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and
          have:

          a)   designed such disclosure controls and procedures, or caused such
               disclosure controls and procedures to be designed under our
               supervision, to ensure that material information relating to the
               registrant, including its consolidated subsidiaries, is made
               known to us by others within those entities, particularly during
               the period in which this report is being prepared;

          b)   designed such internal control over financial reporting, or
               caused such internal control over financial reporting to be
               designed under our supervision, to provide reasonable assurance
               regarding the reliability of financial reporting and the
               preparation of financial statements for external purposes in
               accordance with generally accepted accounting principles

          c)   evaluated the effectiveness of the registrant's disclosure
               controls and procedures and presented in this report
               our conclusions about the effectiveness of the disclosure
               controls and procedures, as of the end of the period covered by
               this report based on such evaluation; and

          d)   disclosed in this report any change in the registrant's
               internal control over financial reporting that occurred
               during the registrant's most recent fiscal quarter
               (the registrant's fourth fiscal quarter in the case
               of an annual report) that has materially affected, or is
               reasonably likely to materially affect, the registrant's
               internal control over financial reporting; and

5.        I have disclosed, based on our most recent evaluation of internal
          control over financial reporting, to the registrant's auditors
          and the audit committee of the registrant's board of directors
          (or persons performing the equivalent functions):

          a)   All significant deficiencies and material weaknesses in the
               design or operation of internal control over financial reporting
               which are reasonably likely to adversely affect the registrant's
               ability to record, process, summarize and report financial
               information; and

          b)   any fraud, whether or not material, that involves management or
               other employees who have a significant role in the registrant's
               internal control over financial reporting.


Dated:  August 11, 2011       By:  /s/ Scott Gerardi
        ---------------       -----------------------------------
                                      Scott Gerardi
                                      Principal Executive Officer
                                      Principal Financial Officer